1. Home
  2. RETO vs POAI Comparison

RETO vs POAI Comparison

Compare RETO & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RETO

ReTo Eco-Solutions Inc.

HOLD

Current Price

$2.61

Market Cap

6.1M

ML Signal

HOLD

Logo Predictive Oncology Inc.

POAI

Predictive Oncology Inc.

HOLD

Current Price

$5.58

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RETO
POAI
Founded
1999
2002
Country
China
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1M
6.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
RETO
POAI
Price
$2.61
$5.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
436.5K
42.7K
Earning Date
05-05-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,109,956.00
$1,664,407.00
Revenue This Year
N/A
$486.27
Revenue Next Year
N/A
$65.50
P/E Ratio
N/A
N/A
Revenue Growth
16864.81
320.71
52 Week Low
$1.77
$3.88
52 Week High
$61.50
$45.90

Technical Indicators

Market Signals
Indicator
RETO
POAI
Relative Strength Index (RSI) 47.59 47.30
Support Level $1.77 $3.88
Resistance Level $3.54 $6.25
Average True Range (ATR) 0.57 0.76
MACD -0.11 0.11
Stochastic Oscillator 24.57 79.01

Price Performance

Historical Comparison
RETO
POAI

About RETO ReTo Eco-Solutions Inc.

ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

Share on Social Networks: